SlideShare a Scribd company logo
1 of 33
Download to read offline
Monocyte Recruitment into
Atherosclerotic plaques
Quantification Methods
Review of the studies done by:
• Gerrity et al
• Steinberg et al
• Willerson et al
• The potential role of SPIO
Initial observation, with the help of EM
(electron microscopy) by Gerrity et all,
led to the hypothesis of “macrophage assisted
lipid clearance mechanism”.
Published in Artery in 1979, he used the swine model
Of hypercholesterolemia. He fed Yorkshire pigs with
high cholesterol diet and sacrifice them at the ages of
12, 15 and 30 weeks. He also used an age-matched
group of pigs as control.
Samples of aortic arch from both lesion and non-lesion
Areas were examined by electron microscopy.
Fatty streak lesions develops as early as 15 weeks of
Age. These lesion although becoming more extensive
In area, will not progress beyond fatty streak up to 30
Weeks of age.
EM studies indicated movement of foam cells through
Endothelium overlying the fatty streak lesion into the
Aortic lumen.
The above mentioned phenomenon may explain
the stability of fatty streaks for a period of time.
It also explains that macrophages may initially
serve as carriers of lipid material out of the plaque.
However, focal endothelial damage would result
from this process, which may contribute to later
lesion progress by introducing SMC proliferating
factors into the wall.
In a 2nd
study by Gerrity et al, published in Atherosclerosis
1988, additional method to trace macrophages was used:
-Monocytes were isolated from peripheral blood of pigs with
Hypercholestrolemia.
-Monocytes were labeled with FITC (fluorocin
Isothiocyanate 1-hydrochloride)
-Labeled monocytes were reinjected back to the animal
-Labeled cells were found in the blood.
-Animals were killed after 9 days, and histology exam was
performed
Result
1)FITC-labeled monocytes were found adherent
to the thickened site of the intima but not to
normal areas.
2)Labelled cells are also found in within the
atherosclerotic lesions.
In the study by S. Patel, James T. Willerson and
Edward Yeh, published in 1997, peritoneal
macrophages of mouse were labeled with fluorescent
latex microspheres and injected into the blood.
Animals were sacrificed after 48 hours, and tissues
obtained for histology.(ApoE deficient mice)
A quantitative survey was done to detect the number of
labeled macrophages in the arterial wall.
Antibodies to ICAM-1, integrin and E-selectin were
Injected 6-8 hours before macrophage injection.
Figure 2. Schematic diagram of the study
area depicting a labeled macrophage
adhering to the plaque.
Figure : a, Distribution of macrophages in
the 10-µm section of aorta in a representative
experiment; b, inhibition of macrophage
recruitment by antibody against 4
or
ICAM-1 but not by anti–E-selectin antibody.
The group of mice that were not treated with
antibody is labeled as positive control.
Appropriate isotype-matched antibody was
used for each specific antibody. Mean of each
treatment group is indicated by a bar.
Comparison of the seven treatment groups
was performed with one-way ANOVA
followed by Scheffé's test for post hoc
pairwise comaprisions. All analyses were
done with SAS statistical programs; P<.05
was considered statistically significant.
Figure:
Macrophages labeled with
fluorescent microspheres adhere
to atherosclerotic plaques.
Results
-Study was performed in 2 groups,(control and test) with
respect to the use of antibodies.
-After 48 hours macrophages were observed adhering to
all stages of plaques.
-The mean number of macrophages in the proximal 1mm
of aortic root was estimated to be 143+17 per aortic root
-Antibodies against ICAM-1 and integrin significantly
reduced the number of macrophage homing.
Lewis et al used labeled leukocytes in vivo, by giving
multiple infusions of tritiated thymidine to pigeons
while being repeatedly bled to induce rapid leukocyte
formation.
A harvested tritium-labeled mononuclear cells then
was transfused to a bird with atherosclerosis.
Autoradiography then showed that 2/3 of the
radiographic grains are associated with foam cells,but
the rest was associated with smooth muscle cells and
endothelial cells. (low sensitivity of the test)
Steinberg et al, in 2000 published their study regarding
a new method of detecting monocytes in the plaque.
The basic idea is the introduction into a recipient animal
of leukocytes differing from those of the recipient by
virtue of one easily identified and quantified genetic
marker.
To minimize manipulation of cells as much as possible
(to avoid activation or damage), Steinberg and his
group used a naturally occurring mutation in the
preliminary experiments, then they transferred the
cells from donor to recipient with a minimum handling.
Rabbit mutation,(NAT-R), loss of gene coding for major
form of arylamine N-acetyl transferase.
10% of New Zealand rabbits are homozygous for a
major deletion in the gene coding for NAT-R.
Homologous deletion inbred were used as donor
and wild type were used as recipient of leukocytes.
Methods:
PCR was the tool to detect the mutated leukocyte.
-Due to its extreme sensitivity, this test is able to detect
A band in a dilution of 5 cells in 1 million unmarked
Cells.
-Animals were sacrificed after 65 hours.
-Time course of the disappearance of donor cells from
the blood stream of the recipient animals were
obtained.
-Tissue samples were tested for the presence of donor cell.
Figure:
A: Time course of the
disappearance of donor monocytes
purified from the blood of a wild-
type donor(NAT-R) and injected
intravenously into a mutant(NAT-S)
recipient.
B: Time course of the disappearance
of donor monocytes from the blood
of a mutant recipient (NAT-S) after
intravenous injection of 45 ml of
Whole blood from a wild type donor
(NAT-R).
Figure : Recovery of donor cells in recipient
tissues 65 hr after injection of purified
NAT-R positive monocytes into an NAT-S
rabbit. The relative quantities of PCR
products are expressed as cpm per µg of
DNA from each tissue (except in the case
of spleen, where the data represent cpm per
20 ng of DNA). Each open circle represents
a value for a sample of DNA carried
separately through PCR and hybridization.
Figure: Leukocyte uptake into the aortic lesions of a mutant cholesterol-fed rabbit
(18 wk) 70 hr after transfusion of 45 ml of whole blood from a wild-type donor.
Data represent the amount of 32
P-labeled probe hybridizing with PCR products
generated from 1 µg of aortic DNA. , Values for duplicate DNA samples carried
separately through PCR and hybridization.As indicated in the inset, the successive
thoracic segments represented equal-length samples along the aorta.
For the atherosclerotic plaque 2 different setting were
Selected, Fatty streaks and more advanced lesions.
They concluded that 623 per million cells in the early
Fatty streaks were donor leukocytes.
In more advanced stage, the aortic arch showed a
maximum number of 3860 donor leukocytes per 1
million cells.(>1% of all the cells in aortic arch).
The rate of leukocyte infiltration and lesion expansion
will vary with time.
Results
The study limitation was the possibility of immune response
interference , because highly inbred strains of rabbits are
not available, and monocyte transfusion should be done
between allogenic animals.
In another study by the same group, the above mentioned
problem was overcome by the following method.
(Arteriosclerosis Thromb Vasc. Biol. August 2000)
They transfused monocytes from a male donor into a female
recipient and then used PCR to amplify the Sry gene
(testis-determining gene) on the Y chromosome.
The animal model was and LDL receptor deficient mice.
Males and females from the same highly inbred strain
can be used as donors and recipients, so that no significant
immune response will occur.
Method
LDL receptor negative mice were obtained. Females who
were to be recipient , were fed an atherogenic diet, for 3-6
months, beginning at 6 to 9 months of age.
All animals showed lesions in the aortic arch covering 13%
to 49% of the total surface area.
Methods
Monocytes collected from male mice, injected into 3 female
mice as control and 3 female mice whom also received
cytokine injection into the peritoneum. (TNF-alpha, IL-1)
Twenty four hour later the animals were euthanized and
aorta obtained for the study.
Results
Figure 4. Effects of combined injection of TNF- and IL-1ß on recruitment of circulating
monocytes to aortic arch of LDL receptor–deficient mice. The experimental animals were
given 0.2 µg each of TNF- and IL-1ß in 0.5 mL of saline intraperitoneally 30 minutes after
receiving a transfusion of donor male monocytes; the control animals received only the
saline. In total, 18 animals were studied, 6 on each of 3 separate days. To take account of the
possible variability in monocyte preparations, the values for the 3 experimental animals on each
experimental day (with use of a single monocyte preparation) were expressed relative to the
mean value in the 3 control animals set equal to 100%. The mean value was 100.0±28.3% for the
9 control animals and 217.5±57.6% for the 9 experimental animals (P<0.0005) by competitive
PCR (A), and the respective values were 100.0±29.5% and 195.5±76.2% (P<0.01) by real-time
PCR (B).
Figure 5. Monocyte recruitment to aortic arch expressed relative to the extent of atherosclerotic
lesions. Results for control animals (•) and for cytokine-treated animals ( ) are separately plotted.
Values for cytokine-treated animals are expressed relative to the mean value in control animals set
to 100%. Note that there was almost no detectable cytokine effect in the animals with the more
extensive lesions, whereas monocyte recruitment was doubled or tripled in the animals with less
extensive lesions.
Results
Results
Cytokine treated mice showed 100% more recruitment
Of monocytes in the aortic wall, compared to the control
Group.
There was no cytokine effect in the animals with >40%
Of the aortic arch covered by lesions.
The data in the control animals show that monocyte
recruitment continues even when 30% to %50 of the
aortic surface is covered by lesions but that the rate of
recruitment is somewhat slower than it is in the earlier
stages of the disease.
SPIO is engulfed by monocyte/macrophage
System upon entry into the body.
Could it be used to detect the dynamic of
macrophage involvement in the atherosclerotic
plaque?
IRON H&E
Hypercholesterolemic Rabbit, Aorta, 4 days after SPIO injection
IRON H&E
Hypercholesterolemic Rabbit, Aorta, 4 days after SPIO injection
IRON H&E
Hypercholesterolemic Rabbit, Aorta, 10 days after SPIO injection
Hypercholesterolemic Rabbit, Aorta, 10 days after SPIO injection
H&E IRON
Hypercholesterolemic Rabbit, Aorta, 10 days after SPIO injection
IRON H&E
Hypercholesterolemic Rabbit, Aorta, 10 days after SPIO injection
IRON H&E

More Related Content

What's hot

Hofstetter PON1 meeting 2015 KOmice corrected
Hofstetter PON1 meeting 2015 KOmice correctedHofstetter PON1 meeting 2015 KOmice corrected
Hofstetter PON1 meeting 2015 KOmice correctedCatherine A. Hofstetter
 
NJ Stem Cell Symposium 2011 Abstract
NJ Stem Cell Symposium 2011 AbstractNJ Stem Cell Symposium 2011 Abstract
NJ Stem Cell Symposium 2011 AbstractChristopher S Park
 
J immunol 2003-harshyne-2302-9
J immunol 2003-harshyne-2302-9J immunol 2003-harshyne-2302-9
J immunol 2003-harshyne-2302-9Elsa von Licy
 
Ablooglu, AJ (2010) Development
Ablooglu, AJ (2010) DevelopmentAblooglu, AJ (2010) Development
Ablooglu, AJ (2010) DevelopmentArarat Ablooglu
 
Regulatory b cells and tolerance in transplantation from animal models to hum...
Regulatory b cells and tolerance in transplantation from animal models to hum...Regulatory b cells and tolerance in transplantation from animal models to hum...
Regulatory b cells and tolerance in transplantation from animal models to hum...Elsa von Licy
 
Infect. Immun.-2011-Fabich-2430-9
Infect. Immun.-2011-Fabich-2430-9Infect. Immun.-2011-Fabich-2430-9
Infect. Immun.-2011-Fabich-2430-9Andrew Fabich
 
1-s2.0-S0021997515000055-main
1-s2.0-S0021997515000055-main1-s2.0-S0021997515000055-main
1-s2.0-S0021997515000055-mainAlison Lee
 
Deleterious Alleles in maize, talk from PAGXXII
Deleterious Alleles in maize, talk from PAGXXIIDeleterious Alleles in maize, talk from PAGXXII
Deleterious Alleles in maize, talk from PAGXXIIjrossibarra
 
Dr. Sid Thakur - Antimicrobial Resistance: Do We Know Everything?
Dr. Sid Thakur - Antimicrobial Resistance: Do We Know Everything?Dr. Sid Thakur - Antimicrobial Resistance: Do We Know Everything?
Dr. Sid Thakur - Antimicrobial Resistance: Do We Know Everything?John Blue
 
2013_CarterEtal_MultiplexPCR-Cronobacter_ AEM
2013_CarterEtal_MultiplexPCR-Cronobacter_ AEM2013_CarterEtal_MultiplexPCR-Cronobacter_ AEM
2013_CarterEtal_MultiplexPCR-Cronobacter_ AEMMonica Pava-Ripoll
 
Activation of surrogate death receptor signalling triggers peroxynitrite depe...
Activation of surrogate death receptor signalling triggers peroxynitrite depe...Activation of surrogate death receptor signalling triggers peroxynitrite depe...
Activation of surrogate death receptor signalling triggers peroxynitrite depe...Saurabh Shekhar
 

What's hot (17)

Hofstetter PON1 meeting 2015 KOmice corrected
Hofstetter PON1 meeting 2015 KOmice correctedHofstetter PON1 meeting 2015 KOmice corrected
Hofstetter PON1 meeting 2015 KOmice corrected
 
NJ Stem Cell Symposium 2011 Abstract
NJ Stem Cell Symposium 2011 AbstractNJ Stem Cell Symposium 2011 Abstract
NJ Stem Cell Symposium 2011 Abstract
 
J immunol 2003-harshyne-2302-9
J immunol 2003-harshyne-2302-9J immunol 2003-harshyne-2302-9
J immunol 2003-harshyne-2302-9
 
Ablooglu, AJ (2010) Development
Ablooglu, AJ (2010) DevelopmentAblooglu, AJ (2010) Development
Ablooglu, AJ (2010) Development
 
Regulatory b cells and tolerance in transplantation from animal models to hum...
Regulatory b cells and tolerance in transplantation from animal models to hum...Regulatory b cells and tolerance in transplantation from animal models to hum...
Regulatory b cells and tolerance in transplantation from animal models to hum...
 
Infect. Immun.-2011-Fabich-2430-9
Infect. Immun.-2011-Fabich-2430-9Infect. Immun.-2011-Fabich-2430-9
Infect. Immun.-2011-Fabich-2430-9
 
1-s2.0-S0021997515000055-main
1-s2.0-S0021997515000055-main1-s2.0-S0021997515000055-main
1-s2.0-S0021997515000055-main
 
Biochemistry Poster
Biochemistry PosterBiochemistry Poster
Biochemistry Poster
 
243 b cell
243 b cell243 b cell
243 b cell
 
Esv2n15
Esv2n15Esv2n15
Esv2n15
 
Deleterious Alleles in maize, talk from PAGXXII
Deleterious Alleles in maize, talk from PAGXXIIDeleterious Alleles in maize, talk from PAGXXII
Deleterious Alleles in maize, talk from PAGXXII
 
Dr. Sid Thakur - Antimicrobial Resistance: Do We Know Everything?
Dr. Sid Thakur - Antimicrobial Resistance: Do We Know Everything?Dr. Sid Thakur - Antimicrobial Resistance: Do We Know Everything?
Dr. Sid Thakur - Antimicrobial Resistance: Do We Know Everything?
 
Elisa hi ai quail
Elisa hi ai quailElisa hi ai quail
Elisa hi ai quail
 
Vaidyanathan VP 05
Vaidyanathan VP 05Vaidyanathan VP 05
Vaidyanathan VP 05
 
Vaidyanathan JIP 04
Vaidyanathan JIP 04Vaidyanathan JIP 04
Vaidyanathan JIP 04
 
2013_CarterEtal_MultiplexPCR-Cronobacter_ AEM
2013_CarterEtal_MultiplexPCR-Cronobacter_ AEM2013_CarterEtal_MultiplexPCR-Cronobacter_ AEM
2013_CarterEtal_MultiplexPCR-Cronobacter_ AEM
 
Activation of surrogate death receptor signalling triggers peroxynitrite depe...
Activation of surrogate death receptor signalling triggers peroxynitrite depe...Activation of surrogate death receptor signalling triggers peroxynitrite depe...
Activation of surrogate death receptor signalling triggers peroxynitrite depe...
 

Viewers also liked

Programming of innate immune cells in diabetic conditions: Emerging epigeneti...
Programming of innate immune cells in diabetic conditions: Emerging epigeneti...Programming of innate immune cells in diabetic conditions: Emerging epigeneti...
Programming of innate immune cells in diabetic conditions: Emerging epigeneti...Conferencia Sindrome Metabolico
 
Mms
MmsMms
MmsIIDC
 
Histiocytosis in children
Histiocytosis in childrenHistiocytosis in children
Histiocytosis in childrenJavaria Rasheed
 
Reactive Atypical Abnormal Morphology of neutrophils
Reactive Atypical Abnormal Morphology of neutrophilsReactive Atypical Abnormal Morphology of neutrophils
Reactive Atypical Abnormal Morphology of neutrophilsMojgan Talebian
 

Viewers also liked (7)

Programming of innate immune cells in diabetic conditions: Emerging epigeneti...
Programming of innate immune cells in diabetic conditions: Emerging epigeneti...Programming of innate immune cells in diabetic conditions: Emerging epigeneti...
Programming of innate immune cells in diabetic conditions: Emerging epigeneti...
 
Macrophages
MacrophagesMacrophages
Macrophages
 
Mms
MmsMms
Mms
 
Immune mechanisms
Immune mechanismsImmune mechanisms
Immune mechanisms
 
Histiocytosis in children
Histiocytosis in childrenHistiocytosis in children
Histiocytosis in children
 
Reactive Atypical Abnormal Morphology of neutrophils
Reactive Atypical Abnormal Morphology of neutrophilsReactive Atypical Abnormal Morphology of neutrophils
Reactive Atypical Abnormal Morphology of neutrophils
 
Lecture 10
Lecture 10Lecture 10
Lecture 10
 

Similar to Monocyte recruitment into atherosclerotic plaques

042 introducing a novel model
042 introducing a novel model042 introducing a novel model
042 introducing a novel modelSHAPE Society
 
The Importance Of Animal Uses In Animals
The Importance Of Animal Uses In AnimalsThe Importance Of Animal Uses In Animals
The Importance Of Animal Uses In AnimalsJessica Lopez
 
Metastatic Breast Cancer
Metastatic Breast CancerMetastatic Breast Cancer
Metastatic Breast CancerChen Yan
 
Leishmania amazonensis INFECTION INDUCES CHANGES IN POTASSIUM PERMEABILITY OF...
Leishmania amazonensis INFECTION INDUCES CHANGES IN POTASSIUM PERMEABILITY OF...Leishmania amazonensis INFECTION INDUCES CHANGES IN POTASSIUM PERMEABILITY OF...
Leishmania amazonensis INFECTION INDUCES CHANGES IN POTASSIUM PERMEABILITY OF...Mariela Marín
 
Apoptosis of lymphocytes in SLE
Apoptosis of lymphocytes in SLEApoptosis of lymphocytes in SLE
Apoptosis of lymphocytes in SLEAboMuaz
 
Screening models for immunomodulator
Screening models for immunomodulatorScreening models for immunomodulator
Screening models for immunomodulatorMr. MOHD FAHAD
 
screeningmodelsforimmunomodulator-180115093755.pdf
screeningmodelsforimmunomodulator-180115093755.pdfscreeningmodelsforimmunomodulator-180115093755.pdf
screeningmodelsforimmunomodulator-180115093755.pdfRinkusingh41606
 
An immunohistochemical analysis of Canine Haemangioma and Haemangiosarcoma
An immunohistochemical analysis of Canine Haemangioma and HaemangiosarcomaAn immunohistochemical analysis of Canine Haemangioma and Haemangiosarcoma
An immunohistochemical analysis of Canine Haemangioma and HaemangiosarcomaRodrigo Shamed Cedillo Flores
 
Intox por ivermectinas
Intox por ivermectinasIntox por ivermectinas
Intox por ivermectinasRoberio Olinda
 
Screening models for testing of immunological factors
Screening models for testing of immunological  factorsScreening models for testing of immunological  factors
Screening models for testing of immunological factorsKundlik Rathod
 
Screening methods of immunomodulators
Screening methods of immunomodulatorsScreening methods of immunomodulators
Screening methods of immunomodulatorsAanchal46
 
Morphology of erythrocyte and hematological parameters of red tilapia (Oreoch...
Morphology of erythrocyte and hematological parameters of red tilapia (Oreoch...Morphology of erythrocyte and hematological parameters of red tilapia (Oreoch...
Morphology of erythrocyte and hematological parameters of red tilapia (Oreoch...Innspub Net
 

Similar to Monocyte recruitment into atherosclerotic plaques (20)

042 introducing a novel model
042 introducing a novel model042 introducing a novel model
042 introducing a novel model
 
Vascular_Poster
Vascular_PosterVascular_Poster
Vascular_Poster
 
The Importance Of Animal Uses In Animals
The Importance Of Animal Uses In AnimalsThe Importance Of Animal Uses In Animals
The Importance Of Animal Uses In Animals
 
2010Ketorolac
2010Ketorolac2010Ketorolac
2010Ketorolac
 
Metastatic Breast Cancer
Metastatic Breast CancerMetastatic Breast Cancer
Metastatic Breast Cancer
 
Esc macrophage homing
Esc macrophage homingEsc macrophage homing
Esc macrophage homing
 
Introducing a novel model
Introducing a novel modelIntroducing a novel model
Introducing a novel model
 
Leishmania amazonensis INFECTION INDUCES CHANGES IN POTASSIUM PERMEABILITY OF...
Leishmania amazonensis INFECTION INDUCES CHANGES IN POTASSIUM PERMEABILITY OF...Leishmania amazonensis INFECTION INDUCES CHANGES IN POTASSIUM PERMEABILITY OF...
Leishmania amazonensis INFECTION INDUCES CHANGES IN POTASSIUM PERMEABILITY OF...
 
Apoptosis of lymphocytes in SLE
Apoptosis of lymphocytes in SLEApoptosis of lymphocytes in SLE
Apoptosis of lymphocytes in SLE
 
Screening models for immunomodulator
Screening models for immunomodulatorScreening models for immunomodulator
Screening models for immunomodulator
 
screeningmodelsforimmunomodulator-180115093755.pdf
screeningmodelsforimmunomodulator-180115093755.pdfscreeningmodelsforimmunomodulator-180115093755.pdf
screeningmodelsforimmunomodulator-180115093755.pdf
 
An immunohistochemical analysis of Canine Haemangioma and Haemangiosarcoma
An immunohistochemical analysis of Canine Haemangioma and HaemangiosarcomaAn immunohistochemical analysis of Canine Haemangioma and Haemangiosarcoma
An immunohistochemical analysis of Canine Haemangioma and Haemangiosarcoma
 
Intox por ivermectinas
Intox por ivermectinasIntox por ivermectinas
Intox por ivermectinas
 
Screening models for testing of immunological factors
Screening models for testing of immunological  factorsScreening models for testing of immunological  factors
Screening models for testing of immunological factors
 
Screening methods of immunomodulators
Screening methods of immunomodulatorsScreening methods of immunomodulators
Screening methods of immunomodulators
 
Morphology of erythrocyte and hematological parameters of red tilapia (Oreoch...
Morphology of erythrocyte and hematological parameters of red tilapia (Oreoch...Morphology of erythrocyte and hematological parameters of red tilapia (Oreoch...
Morphology of erythrocyte and hematological parameters of red tilapia (Oreoch...
 
Experimental animal models
Experimental animal modelsExperimental animal models
Experimental animal models
 
Experimental animal models
Experimental animal modelsExperimental animal models
Experimental animal models
 
Simvastatin Treatment Prevents Cell Damage and Regulates Angiogenesis in a Ra...
Simvastatin Treatment Prevents Cell Damage and Regulates Angiogenesis in a Ra...Simvastatin Treatment Prevents Cell Damage and Regulates Angiogenesis in a Ra...
Simvastatin Treatment Prevents Cell Damage and Regulates Angiogenesis in a Ra...
 
Suppress lung cancer progression via up regulation of linc rna-p21
Suppress lung cancer progression via up regulation of linc rna-p21Suppress lung cancer progression via up regulation of linc rna-p21
Suppress lung cancer progression via up regulation of linc rna-p21
 

More from Society for Heart Attack Prevention and Eradication

More from Society for Heart Attack Prevention and Eradication (20)

AHA SHAPE Symposium 2017 Dr. Naghavi Presentation
AHA SHAPE Symposium 2017 Dr. Naghavi PresentationAHA SHAPE Symposium 2017 Dr. Naghavi Presentation
AHA SHAPE Symposium 2017 Dr. Naghavi Presentation
 
AHA SHAPE Symposium 2017 Dr. Kloner Presentation
AHA SHAPE Symposium 2017 Dr. Kloner PresentationAHA SHAPE Symposium 2017 Dr. Kloner Presentation
AHA SHAPE Symposium 2017 Dr. Kloner Presentation
 
AHA SHAPE Symposium 2017 Dr. Greenland Presentation
AHA SHAPE Symposium 2017 Dr. Greenland PresentationAHA SHAPE Symposium 2017 Dr. Greenland Presentation
AHA SHAPE Symposium 2017 Dr. Greenland Presentation
 
AHA SHAPE Symposium 2017 Dr. Yen Presentation
AHA SHAPE Symposium 2017 Dr. Yen PresentationAHA SHAPE Symposium 2017 Dr. Yen Presentation
AHA SHAPE Symposium 2017 Dr. Yen Presentation
 
AHA SHAPE Symposium 2017 Dr. Slomka Presentation
AHA SHAPE Symposium 2017 Dr. Slomka PresentationAHA SHAPE Symposium 2017 Dr. Slomka Presentation
AHA SHAPE Symposium 2017 Dr. Slomka Presentation
 
Vu lplaque1 pasterkamp
Vu lplaque1 pasterkampVu lplaque1 pasterkamp
Vu lplaque1 pasterkamp
 
Vulnerable plaque vulnerable patient
Vulnerable plaque vulnerable patientVulnerable plaque vulnerable patient
Vulnerable plaque vulnerable patient
 
Vulnerable plaque overview
Vulnerable plaque overviewVulnerable plaque overview
Vulnerable plaque overview
 
Vulnerable patient talk in poland
Vulnerable patient talk in polandVulnerable patient talk in poland
Vulnerable patient talk in poland
 
Vulnerable patient slides without movies
Vulnerable patient slides without moviesVulnerable patient slides without movies
Vulnerable patient slides without movies
 
Vulnerable patient mar 04
Vulnerable patient mar 04Vulnerable patient mar 04
Vulnerable patient mar 04
 
Vulnerable (thrombogenic blood
Vulnerable (thrombogenic bloodVulnerable (thrombogenic blood
Vulnerable (thrombogenic blood
 
Vuln shape aha 2005
Vuln shape aha 2005Vuln shape aha 2005
Vuln shape aha 2005
 
Vuln plaque poster burke
Vuln plaque poster burkeVuln plaque poster burke
Vuln plaque poster burke
 
Vp watch editorial_slide 25short-
Vp watch editorial_slide 25short-Vp watch editorial_slide 25short-
Vp watch editorial_slide 25short-
 
Vp watch editorial_slide25
Vp watch editorial_slide25Vp watch editorial_slide25
Vp watch editorial_slide25
 
Vp watch editorial_slide25short-
Vp watch editorial_slide25short-Vp watch editorial_slide25short-
Vp watch editorial_slide25short-
 
Vp watch2002
Vp watch2002Vp watch2002
Vp watch2002
 
Vp symposium31602
Vp symposium31602Vp symposium31602
Vp symposium31602
 
Vpschoenhagen
VpschoenhagenVpschoenhagen
Vpschoenhagen
 

Recently uploaded

EMBRYOLOGY AND FOETAL DEVELOPMENT-mayu.pdf
EMBRYOLOGY AND FOETAL DEVELOPMENT-mayu.pdfEMBRYOLOGY AND FOETAL DEVELOPMENT-mayu.pdf
EMBRYOLOGY AND FOETAL DEVELOPMENT-mayu.pdfMayuriGamit2
 
The Art and the Science of UK General Practice A historical review and timeli...
The Art and the Science of UK General Practice A historical review and timeli...The Art and the Science of UK General Practice A historical review and timeli...
The Art and the Science of UK General Practice A historical review and timeli...JakeMatthews12
 
SGK BỆNH LÝ GOUT YHN hay lắm nha aaaa.pdf
SGK BỆNH LÝ GOUT YHN hay lắm nha aaaa.pdfSGK BỆNH LÝ GOUT YHN hay lắm nha aaaa.pdf
SGK BỆNH LÝ GOUT YHN hay lắm nha aaaa.pdfHongBiThi1
 
Laryngeal papillomatosis .pdf ENT BY QUICKMEDTALK
Laryngeal papillomatosis .pdf ENT BY QUICKMEDTALKLaryngeal papillomatosis .pdf ENT BY QUICKMEDTALK
Laryngeal papillomatosis .pdf ENT BY QUICKMEDTALKQuick MedTalk
 
Explaining "pathology" in digital pathology
Explaining "pathology" in digital pathologyExplaining "pathology" in digital pathology
Explaining "pathology" in digital pathologyYves Sucaet
 
Tracheostomy .pdf ENT by QuickMedTALK. getting things done on time
Tracheostomy .pdf ENT by QuickMedTALK. getting things done on timeTracheostomy .pdf ENT by QuickMedTALK. getting things done on time
Tracheostomy .pdf ENT by QuickMedTALK. getting things done on timeQuick MedTalk
 
Problems associated with the production of recombinant protein.pdf
Problems associated with the production of recombinant protein.pdfProblems associated with the production of recombinant protein.pdf
Problems associated with the production of recombinant protein.pdfNetHelix
 
Methicillin-resistant Staphylococcus Aureus (MRSA)
Methicillin-resistant Staphylococcus Aureus (MRSA)Methicillin-resistant Staphylococcus Aureus (MRSA)
Methicillin-resistant Staphylococcus Aureus (MRSA)Ahmad Thanin
 
Derma Pharmaceutical Franchise Company - Solace Biotech Limited
Derma Pharmaceutical Franchise Company - Solace Biotech LimitedDerma Pharmaceutical Franchise Company - Solace Biotech Limited
Derma Pharmaceutical Franchise Company - Solace Biotech LimitedSBL DIGITAL
 
Thyroid hormones- synthesis, secretion, functions and disorders
Thyroid hormones- synthesis, secretion, functions and disordersThyroid hormones- synthesis, secretion, functions and disorders
Thyroid hormones- synthesis, secretion, functions and disordersSai Sailesh Kumar Goothy
 
Neutraceuticals, Herb-drug & Herb-food inetractions
Neutraceuticals, Herb-drug & Herb-food inetractionsNeutraceuticals, Herb-drug & Herb-food inetractions
Neutraceuticals, Herb-drug & Herb-food inetractionsPradnya Wadekar
 
Routine Medicine Laboratory Testing _ CÁC XÉT NGHIỆM THƯỜNG QUY ÁP DỤNG TRON...
Routine Medicine Laboratory Testing  _ CÁC XÉT NGHIỆM THƯỜNG QUY ÁP DỤNG TRON...Routine Medicine Laboratory Testing  _ CÁC XÉT NGHIỆM THƯỜNG QUY ÁP DỤNG TRON...
Routine Medicine Laboratory Testing _ CÁC XÉT NGHIỆM THƯỜNG QUY ÁP DỤNG TRON...DUY NGUYEN PHUC
 
ANATOMY OF THE CEREBRUM WITH CLINICAL ANATOMY.pptx
ANATOMY OF THE CEREBRUM WITH CLINICAL ANATOMY.pptxANATOMY OF THE CEREBRUM WITH CLINICAL ANATOMY.pptx
ANATOMY OF THE CEREBRUM WITH CLINICAL ANATOMY.pptxsiddharthroy26587
 
Human Skeletal System_By Anupam Das......
Human Skeletal System_By Anupam Das......Human Skeletal System_By Anupam Das......
Human Skeletal System_By Anupam Das......anupamdas2143
 
INTRODUCTION TO THE FORENSIC SCIENCE.ppt
INTRODUCTION TO THE FORENSIC SCIENCE.pptINTRODUCTION TO THE FORENSIC SCIENCE.ppt
INTRODUCTION TO THE FORENSIC SCIENCE.pptKavitha Krishnan
 
HERPES SIMPLEX VIRUS 12032019 TUESDAY pptx
HERPES SIMPLEX VIRUS 12032019 TUESDAY  pptxHERPES SIMPLEX VIRUS 12032019 TUESDAY  pptx
HERPES SIMPLEX VIRUS 12032019 TUESDAY pptxPulkitMittal54
 
Neurological Evaluation of Acute Ischemic stroke in Emergency Room
Neurological Evaluation of Acute Ischemic stroke in Emergency RoomNeurological Evaluation of Acute Ischemic stroke in Emergency Room
Neurological Evaluation of Acute Ischemic stroke in Emergency RoomSudhir Kumar
 
airway management recorded for S2.pptx
airway management  recorded  for S2.pptxairway management  recorded  for S2.pptx
airway management recorded for S2.pptxnakera38
 

Recently uploaded (20)

EMBRYOLOGY AND FOETAL DEVELOPMENT-mayu.pdf
EMBRYOLOGY AND FOETAL DEVELOPMENT-mayu.pdfEMBRYOLOGY AND FOETAL DEVELOPMENT-mayu.pdf
EMBRYOLOGY AND FOETAL DEVELOPMENT-mayu.pdf
 
The Art and the Science of UK General Practice A historical review and timeli...
The Art and the Science of UK General Practice A historical review and timeli...The Art and the Science of UK General Practice A historical review and timeli...
The Art and the Science of UK General Practice A historical review and timeli...
 
SGK BỆNH LÝ GOUT YHN hay lắm nha aaaa.pdf
SGK BỆNH LÝ GOUT YHN hay lắm nha aaaa.pdfSGK BỆNH LÝ GOUT YHN hay lắm nha aaaa.pdf
SGK BỆNH LÝ GOUT YHN hay lắm nha aaaa.pdf
 
Laryngeal papillomatosis .pdf ENT BY QUICKMEDTALK
Laryngeal papillomatosis .pdf ENT BY QUICKMEDTALKLaryngeal papillomatosis .pdf ENT BY QUICKMEDTALK
Laryngeal papillomatosis .pdf ENT BY QUICKMEDTALK
 
Explaining "pathology" in digital pathology
Explaining "pathology" in digital pathologyExplaining "pathology" in digital pathology
Explaining "pathology" in digital pathology
 
Evolving Concepts in the Pathogenesis of Inflammatory Dermatologic Disorders ...
Evolving Concepts in the Pathogenesis of Inflammatory Dermatologic Disorders ...Evolving Concepts in the Pathogenesis of Inflammatory Dermatologic Disorders ...
Evolving Concepts in the Pathogenesis of Inflammatory Dermatologic Disorders ...
 
Tracheostomy .pdf ENT by QuickMedTALK. getting things done on time
Tracheostomy .pdf ENT by QuickMedTALK. getting things done on timeTracheostomy .pdf ENT by QuickMedTALK. getting things done on time
Tracheostomy .pdf ENT by QuickMedTALK. getting things done on time
 
Problems associated with the production of recombinant protein.pdf
Problems associated with the production of recombinant protein.pdfProblems associated with the production of recombinant protein.pdf
Problems associated with the production of recombinant protein.pdf
 
Methicillin-resistant Staphylococcus Aureus (MRSA)
Methicillin-resistant Staphylococcus Aureus (MRSA)Methicillin-resistant Staphylococcus Aureus (MRSA)
Methicillin-resistant Staphylococcus Aureus (MRSA)
 
Derma Pharmaceutical Franchise Company - Solace Biotech Limited
Derma Pharmaceutical Franchise Company - Solace Biotech LimitedDerma Pharmaceutical Franchise Company - Solace Biotech Limited
Derma Pharmaceutical Franchise Company - Solace Biotech Limited
 
Thyroid hormones- synthesis, secretion, functions and disorders
Thyroid hormones- synthesis, secretion, functions and disordersThyroid hormones- synthesis, secretion, functions and disorders
Thyroid hormones- synthesis, secretion, functions and disorders
 
Neutraceuticals, Herb-drug & Herb-food inetractions
Neutraceuticals, Herb-drug & Herb-food inetractionsNeutraceuticals, Herb-drug & Herb-food inetractions
Neutraceuticals, Herb-drug & Herb-food inetractions
 
Routine Medicine Laboratory Testing _ CÁC XÉT NGHIỆM THƯỜNG QUY ÁP DỤNG TRON...
Routine Medicine Laboratory Testing  _ CÁC XÉT NGHIỆM THƯỜNG QUY ÁP DỤNG TRON...Routine Medicine Laboratory Testing  _ CÁC XÉT NGHIỆM THƯỜNG QUY ÁP DỤNG TRON...
Routine Medicine Laboratory Testing _ CÁC XÉT NGHIỆM THƯỜNG QUY ÁP DỤNG TRON...
 
ANATOMY OF THE CEREBRUM WITH CLINICAL ANATOMY.pptx
ANATOMY OF THE CEREBRUM WITH CLINICAL ANATOMY.pptxANATOMY OF THE CEREBRUM WITH CLINICAL ANATOMY.pptx
ANATOMY OF THE CEREBRUM WITH CLINICAL ANATOMY.pptx
 
Human Skeletal System_By Anupam Das......
Human Skeletal System_By Anupam Das......Human Skeletal System_By Anupam Das......
Human Skeletal System_By Anupam Das......
 
Oral disorders .pptx
Oral disorders .pptxOral disorders .pptx
Oral disorders .pptx
 
INTRODUCTION TO THE FORENSIC SCIENCE.ppt
INTRODUCTION TO THE FORENSIC SCIENCE.pptINTRODUCTION TO THE FORENSIC SCIENCE.ppt
INTRODUCTION TO THE FORENSIC SCIENCE.ppt
 
HERPES SIMPLEX VIRUS 12032019 TUESDAY pptx
HERPES SIMPLEX VIRUS 12032019 TUESDAY  pptxHERPES SIMPLEX VIRUS 12032019 TUESDAY  pptx
HERPES SIMPLEX VIRUS 12032019 TUESDAY pptx
 
Neurological Evaluation of Acute Ischemic stroke in Emergency Room
Neurological Evaluation of Acute Ischemic stroke in Emergency RoomNeurological Evaluation of Acute Ischemic stroke in Emergency Room
Neurological Evaluation of Acute Ischemic stroke in Emergency Room
 
airway management recorded for S2.pptx
airway management  recorded  for S2.pptxairway management  recorded  for S2.pptx
airway management recorded for S2.pptx
 

Monocyte recruitment into atherosclerotic plaques

  • 1. Monocyte Recruitment into Atherosclerotic plaques Quantification Methods
  • 2. Review of the studies done by: • Gerrity et al • Steinberg et al • Willerson et al • The potential role of SPIO
  • 3. Initial observation, with the help of EM (electron microscopy) by Gerrity et all, led to the hypothesis of “macrophage assisted lipid clearance mechanism”. Published in Artery in 1979, he used the swine model Of hypercholesterolemia. He fed Yorkshire pigs with high cholesterol diet and sacrifice them at the ages of 12, 15 and 30 weeks. He also used an age-matched group of pigs as control. Samples of aortic arch from both lesion and non-lesion Areas were examined by electron microscopy.
  • 4. Fatty streak lesions develops as early as 15 weeks of Age. These lesion although becoming more extensive In area, will not progress beyond fatty streak up to 30 Weeks of age. EM studies indicated movement of foam cells through Endothelium overlying the fatty streak lesion into the Aortic lumen.
  • 5. The above mentioned phenomenon may explain the stability of fatty streaks for a period of time. It also explains that macrophages may initially serve as carriers of lipid material out of the plaque. However, focal endothelial damage would result from this process, which may contribute to later lesion progress by introducing SMC proliferating factors into the wall.
  • 6. In a 2nd study by Gerrity et al, published in Atherosclerosis 1988, additional method to trace macrophages was used: -Monocytes were isolated from peripheral blood of pigs with Hypercholestrolemia. -Monocytes were labeled with FITC (fluorocin Isothiocyanate 1-hydrochloride) -Labeled monocytes were reinjected back to the animal -Labeled cells were found in the blood. -Animals were killed after 9 days, and histology exam was performed
  • 7. Result 1)FITC-labeled monocytes were found adherent to the thickened site of the intima but not to normal areas. 2)Labelled cells are also found in within the atherosclerotic lesions.
  • 8. In the study by S. Patel, James T. Willerson and Edward Yeh, published in 1997, peritoneal macrophages of mouse were labeled with fluorescent latex microspheres and injected into the blood. Animals were sacrificed after 48 hours, and tissues obtained for histology.(ApoE deficient mice) A quantitative survey was done to detect the number of labeled macrophages in the arterial wall. Antibodies to ICAM-1, integrin and E-selectin were Injected 6-8 hours before macrophage injection.
  • 9. Figure 2. Schematic diagram of the study area depicting a labeled macrophage adhering to the plaque.
  • 10. Figure : a, Distribution of macrophages in the 10-µm section of aorta in a representative experiment; b, inhibition of macrophage recruitment by antibody against 4 or ICAM-1 but not by anti–E-selectin antibody. The group of mice that were not treated with antibody is labeled as positive control. Appropriate isotype-matched antibody was used for each specific antibody. Mean of each treatment group is indicated by a bar. Comparison of the seven treatment groups was performed with one-way ANOVA followed by Scheffé's test for post hoc pairwise comaprisions. All analyses were done with SAS statistical programs; P<.05 was considered statistically significant.
  • 11. Figure: Macrophages labeled with fluorescent microspheres adhere to atherosclerotic plaques.
  • 12. Results -Study was performed in 2 groups,(control and test) with respect to the use of antibodies. -After 48 hours macrophages were observed adhering to all stages of plaques. -The mean number of macrophages in the proximal 1mm of aortic root was estimated to be 143+17 per aortic root -Antibodies against ICAM-1 and integrin significantly reduced the number of macrophage homing.
  • 13. Lewis et al used labeled leukocytes in vivo, by giving multiple infusions of tritiated thymidine to pigeons while being repeatedly bled to induce rapid leukocyte formation. A harvested tritium-labeled mononuclear cells then was transfused to a bird with atherosclerosis. Autoradiography then showed that 2/3 of the radiographic grains are associated with foam cells,but the rest was associated with smooth muscle cells and endothelial cells. (low sensitivity of the test)
  • 14. Steinberg et al, in 2000 published their study regarding a new method of detecting monocytes in the plaque. The basic idea is the introduction into a recipient animal of leukocytes differing from those of the recipient by virtue of one easily identified and quantified genetic marker.
  • 15. To minimize manipulation of cells as much as possible (to avoid activation or damage), Steinberg and his group used a naturally occurring mutation in the preliminary experiments, then they transferred the cells from donor to recipient with a minimum handling. Rabbit mutation,(NAT-R), loss of gene coding for major form of arylamine N-acetyl transferase. 10% of New Zealand rabbits are homozygous for a major deletion in the gene coding for NAT-R. Homologous deletion inbred were used as donor and wild type were used as recipient of leukocytes.
  • 16. Methods: PCR was the tool to detect the mutated leukocyte. -Due to its extreme sensitivity, this test is able to detect A band in a dilution of 5 cells in 1 million unmarked Cells. -Animals were sacrificed after 65 hours. -Time course of the disappearance of donor cells from the blood stream of the recipient animals were obtained. -Tissue samples were tested for the presence of donor cell.
  • 17. Figure: A: Time course of the disappearance of donor monocytes purified from the blood of a wild- type donor(NAT-R) and injected intravenously into a mutant(NAT-S) recipient. B: Time course of the disappearance of donor monocytes from the blood of a mutant recipient (NAT-S) after intravenous injection of 45 ml of Whole blood from a wild type donor (NAT-R).
  • 18. Figure : Recovery of donor cells in recipient tissues 65 hr after injection of purified NAT-R positive monocytes into an NAT-S rabbit. The relative quantities of PCR products are expressed as cpm per µg of DNA from each tissue (except in the case of spleen, where the data represent cpm per 20 ng of DNA). Each open circle represents a value for a sample of DNA carried separately through PCR and hybridization.
  • 19. Figure: Leukocyte uptake into the aortic lesions of a mutant cholesterol-fed rabbit (18 wk) 70 hr after transfusion of 45 ml of whole blood from a wild-type donor. Data represent the amount of 32 P-labeled probe hybridizing with PCR products generated from 1 µg of aortic DNA. , Values for duplicate DNA samples carried separately through PCR and hybridization.As indicated in the inset, the successive thoracic segments represented equal-length samples along the aorta.
  • 20. For the atherosclerotic plaque 2 different setting were Selected, Fatty streaks and more advanced lesions. They concluded that 623 per million cells in the early Fatty streaks were donor leukocytes. In more advanced stage, the aortic arch showed a maximum number of 3860 donor leukocytes per 1 million cells.(>1% of all the cells in aortic arch). The rate of leukocyte infiltration and lesion expansion will vary with time. Results
  • 21. The study limitation was the possibility of immune response interference , because highly inbred strains of rabbits are not available, and monocyte transfusion should be done between allogenic animals. In another study by the same group, the above mentioned problem was overcome by the following method. (Arteriosclerosis Thromb Vasc. Biol. August 2000) They transfused monocytes from a male donor into a female recipient and then used PCR to amplify the Sry gene (testis-determining gene) on the Y chromosome.
  • 22. The animal model was and LDL receptor deficient mice. Males and females from the same highly inbred strain can be used as donors and recipients, so that no significant immune response will occur. Method LDL receptor negative mice were obtained. Females who were to be recipient , were fed an atherogenic diet, for 3-6 months, beginning at 6 to 9 months of age. All animals showed lesions in the aortic arch covering 13% to 49% of the total surface area.
  • 23. Methods Monocytes collected from male mice, injected into 3 female mice as control and 3 female mice whom also received cytokine injection into the peritoneum. (TNF-alpha, IL-1) Twenty four hour later the animals were euthanized and aorta obtained for the study.
  • 24. Results Figure 4. Effects of combined injection of TNF- and IL-1ß on recruitment of circulating monocytes to aortic arch of LDL receptor–deficient mice. The experimental animals were given 0.2 µg each of TNF- and IL-1ß in 0.5 mL of saline intraperitoneally 30 minutes after receiving a transfusion of donor male monocytes; the control animals received only the saline. In total, 18 animals were studied, 6 on each of 3 separate days. To take account of the possible variability in monocyte preparations, the values for the 3 experimental animals on each experimental day (with use of a single monocyte preparation) were expressed relative to the mean value in the 3 control animals set equal to 100%. The mean value was 100.0±28.3% for the 9 control animals and 217.5±57.6% for the 9 experimental animals (P<0.0005) by competitive PCR (A), and the respective values were 100.0±29.5% and 195.5±76.2% (P<0.01) by real-time PCR (B).
  • 25. Figure 5. Monocyte recruitment to aortic arch expressed relative to the extent of atherosclerotic lesions. Results for control animals (•) and for cytokine-treated animals ( ) are separately plotted. Values for cytokine-treated animals are expressed relative to the mean value in control animals set to 100%. Note that there was almost no detectable cytokine effect in the animals with the more extensive lesions, whereas monocyte recruitment was doubled or tripled in the animals with less extensive lesions. Results
  • 26. Results Cytokine treated mice showed 100% more recruitment Of monocytes in the aortic wall, compared to the control Group. There was no cytokine effect in the animals with >40% Of the aortic arch covered by lesions. The data in the control animals show that monocyte recruitment continues even when 30% to %50 of the aortic surface is covered by lesions but that the rate of recruitment is somewhat slower than it is in the earlier stages of the disease.
  • 27. SPIO is engulfed by monocyte/macrophage System upon entry into the body. Could it be used to detect the dynamic of macrophage involvement in the atherosclerotic plaque?
  • 28. IRON H&E Hypercholesterolemic Rabbit, Aorta, 4 days after SPIO injection
  • 29. IRON H&E Hypercholesterolemic Rabbit, Aorta, 4 days after SPIO injection
  • 30. IRON H&E Hypercholesterolemic Rabbit, Aorta, 10 days after SPIO injection
  • 31. Hypercholesterolemic Rabbit, Aorta, 10 days after SPIO injection H&E IRON
  • 32. Hypercholesterolemic Rabbit, Aorta, 10 days after SPIO injection IRON H&E
  • 33. Hypercholesterolemic Rabbit, Aorta, 10 days after SPIO injection IRON H&E